Merck & Co., Inc. (MRK)

Healthcare

$143.81

LAST CLOSE · OCT 1

Merck & Co., Inc. (MRK) is a Healthcare stock tracked by StreetAlpha. It last closed at $143.81 on Oct 1. MRK reports earnings on Thu, Oct 29, 2026. The average 12-month price target from 15 analysts is $164.67 (+14.5% from the last close), with a high of $180.00 and a low of $140.00. Analyst consensus is Strong Buy, based on the latest ratings from 15 firms (13 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 12 whale options trades in MRK, 50% of them bullish and 50% bearish. In the past 30 days there were 21 dark pool prints totaling $59.7M, the largest $22.5M.

FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily Cboe FLEX report for unusually large, long-dated positions.

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MRK is in one of them and how their past MRK trades turned out.

StreetAlpha hasn't covered MRK in an article yet. Here's the latest on the wider market.